Gut microbiome effects on cardiometabolic disease through metabolism-modifying metabolites (Gut-MMM)
Forskningsprojekt , 2016 – 2022

Evidence indicates that the bacterial flora in the human gastrointestinal tract substantially influences metabolism and development of cardiometabolic diseases. Nevertheless, the extent to which these factors are linked and whether pharmaceuticals can be developed on this basis are currently unclear. The underlying hypothesis of the project is that microbially synthesized molecules do not simply play a role as the body’s energy metabolizers and building blocks; they also play an important role as signal molecules that interact with receptors in endocrine organs.

Deltagare

Jens B Nielsen (kontakt)

Professor vid Chalmers, Biologi och bioteknik, Systembiologi

Samarbetspartners

Köpenhamns universitet

Köbenhavn, Denmark

Universiteit Van Amsterdam

Amsterdam, Netherlands

Finansiering

Novo Nordisk Fonden

Finansierar Chalmers deltagande under 2016–2022

Relaterade styrkeområden och infrastruktur

Hållbar utveckling

Drivkrafter

Livsvetenskaper och teknik (2010-2018)

Styrkeområden

Mer information

Senast uppdaterat

2019-01-18